Is desmopressin likely to be effective? |
• Baseline VWF level >10% |
|
• Conduct desmopressin trial (IV, SC, IN) |
|
• Test VWF:Ag, VWF:RCo, and FVIII:C levels at 1, 2, and 4 hours |
|
• Positive response both FVIII and VWF > 50% after administration |
Addition of adjunctive therapies |
• Antifibrinolytics |
|
• For menorrhagia: oral contraceptive or levonorgestrel-releasing IUD |
VWF concentrates |
• If desmopressin response is inadequate |
|
• If desmopressin is required for several consecutive days |
|
• Dosing/product considerations |
|
VWF/FVIII ratio |
|
VWF multimer profile |
|
Dosing by VWF:RCo or FVIII:C |
|
Potential for prophylactic schedule |
|
Rare development of VWF alloantibodies |